Adaptation posologique chez les patients insuffisants rénaux chroniques et évaluation de la fonction rénale : focus sur les patients de cardiologie

Coresh, 2003, Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey, Am J Kidney Dis, 41, 1, 10.1053/ajkd.2003.50007 Levey, 2005, Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 67, 2089, 10.1111/j.1523-1755.2005.00365.x National Kidney Foundation, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Bongard, 2012, [Assessment and characteristics of chronic renal insufficiency in France], Ann Cardiol Angeiol (Paris), 61, 239, 10.1016/j.ancard.2012.03.003 Franczyk-Skóra, 2012, Prevention of sudden cardiac death in patients with chronic kidney disease, BMC Nephrol, 13, 162, 10.1186/1471-2369-13-162 Launay-Vacher, 2012, [How to adjust the dose of drugs in chronic kidney disease?], Rev Prat, 62, 309 Verbeeck, 2009, Pharmacokinetics and dosage adjustment in patients with renal dysfunction, Eur J Clin Pharmacol, 65, 757, 10.1007/s00228-009-0678-8 Nolin, 2003, Hepatic drug metabolism and transport in patients with kidney disease, Am J Kidney Dis, 42, 906, 10.1016/j.ajkd.2003.07.019 Hollander, 1999, Intestinal permeability, leaky gut, and intestinal disorders, Curr Gastroenterol Rep, 1, 410, 10.1007/s11894-999-0023-5 Leblond, 2002, Downregulation of intestinal cytochrome p450 in chronic renal failure, J Am Soc Nephrol, 13, 1579, 10.1097/01.ASN.0000017575.50319.77 Bianchetti, 1976, Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment, Clin Pharmacokinet, 1, 373, 10.2165/00003088-197601050-00004 Dreisbach, 2003, Cytochrome P4502C9 activity in end-stage renal disease, Clin Pharmacol Ther, 73, 475, 10.1016/S0009-9236(03)00015-8 Matzke, 2011, Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 80, 1122, 10.1038/ki.2011.322 Choukroun, 2010, [Debate concerning the optimal blockage of the renin-angiotensin system], Nephrol Ther, 6 Spec No 1, H1, 10.1016/S1769-7255(10)70001-8 Roux, 1980, Pharmacokinetics of acebutolol in patients with all grades of renal failure, Eur J Clin Pharmacol, 17, 339, 10.1007/BF00558446 Smith, 1983, Acebutolol pharmacokinetics in renal failure, Br J Clin Pharmacol, 16, 253, 10.1111/j.1365-2125.1983.tb02158.x Stevens, 2013, Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline, Ann Intern Med, 158, 825, 10.7326/0003-4819-158-11-201306040-00007 Karie, 2006, [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant], Presse Med, 35, 219, 10.1016/S0755-4982(06)74557-2 Mychaleckyj, 2012, Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants, Diabetes Care, 35, 1008, 10.2337/dc11-1811 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int Suppl, 3, 1 Skali, 2011, Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation, Am Heart J, 162, 548, 10.1016/j.ahj.2011.06.006 Plischke, 2013, Renal function in heart failure: a disparity between estimating function and predicting mortality risk, Eur J Heart Fail, 15, 763, 10.1093/eurjhf/hft022 Matsushita, 2010, Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study, Am J Kidney Dis, 55, 648, 10.1053/j.ajkd.2009.12.016 Stevens, 2011, Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP), Am J Kidney Dis, 57, S9, 10.1053/j.ajkd.2010.11.007 Park, 2012, A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment, Ann Pharmacother, 46, 1174, 10.1345/aph.1Q757 Aronoff, 2007